EUVIMEDEUVIMED entdecken
Crossref

Quinoid‐Engineered Small‐Molecule Photothermal Agents Ignite Deep‐Tissue Tumor Photothermal‐Immunotherapy Driven by 1064 nm Light

Huilin Xie, Ying Peng, Rufan Mo, Yixuan Shao, Shibo Cheng, Junyi Cai, Yongliang Zhan, Xinyuan Wang, Ryan T. K. Kwok, Jacky W. Y. Lam, Yongye Liang, Lianrui Hu und 2 weitere

Advanced Functional Materials · 2026-02 · 36 (13)

DOI: 10.1002/adfm.202517631 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 16.09.2025. Verfasst von Huilin Xie und 13 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Science, Technology and Innovation Commission of Shenzhen Municipality.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Developing small‐molecule photothermal agents (PTAs) with strong absorption in the NIR‐II window (1000‐1700 nm) remains a significant challenge for effective photothermal therapy (PTT) of deep‐seated tumors. Here, a quinoidal engineering strategy is presented to construct a 1064 nm‐excitable small‐molecule PTA, termed BPT‐FNC, which features a highly quinonized naphthalenedione‐based terminal group, an open‐shell singlet diradical ground state, and thermally accessible triplet states. These electronic characteristics endow BPT‐FNC with pronounced NIR‐II absorption, promoting efficient nonradiative decay and high photothermal conversion efficiency. Under 1064 nm laser irradiation at clinically permissible power densities, BPT‐FNC nanoaggregates enable effective deep‐tissue PTT. Notably, it also triggers pyroptosis and promotes the release of immunogenic damage‐associated molecular patterns (DAMPs), thereby inducing immunogenic cell death (ICD) and stimulating systemic anti‐tumor immune responses. This work showcases a rational molecular design paradigm that integrates quinoidal structure, NIR‐II photothermal functionality, and immune activation, offering a promising platform for synergistic photothermal‐immunotherapy in precision cancer treatment.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Science, Technology and Innovation Commission of Shenzhen Municipality
  • Innovation and Technology Commission
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Xie, H., Peng, Y., Mo, R., Shao, Y., Cheng, S., Cai, J., Zhan, Y., Wang, X., Kwok, R. T. K., Lam, J. W. Y., Liang, Y., Hu, L., Zhang, J., & Tang, B. Z. (2026). Quinoid‐Engineered Small‐Molecule Photothermal Agents Ignite Deep‐Tissue Tumor Photothermal‐Immunotherapy Driven by 1064 nm Light. Advanced Functional Materials, 36(13). https://doi.org/10.1002/adfm.202517631

Vancouver

Xie H, Peng Y, Mo R, Shao Y, Cheng S, Cai J, et al. Quinoid‐Engineered Small‐Molecule Photothermal Agents Ignite Deep‐Tissue Tumor Photothermal‐Immunotherapy Driven by 1064 nm Light. Advanced Functional Materials. 2026;36(13). doi:10.1002/adfm.202517631

BibTeX
@article{Xie2026,
  author = {Xie, Huilin and Peng, Ying and Mo, Rufan and Shao, Yixuan and Cheng, Shibo and Cai, Junyi and Zhan, Yongliang and Wang, Xinyuan and Kwok, Ryan T. K. and Lam, Jacky W. Y. and Liang, Yongye and Hu, Lianrui and Zhang, Jianquan and Tang, Ben Zhong},
  title = {Quinoid‐Engineered Small‐Molecule Photothermal Agents Ignite Deep‐Tissue Tumor Photothermal‐Immunotherapy Driven by 1064 nm Light},
  journal = {Advanced Functional Materials},
  year = {2026},
  volume = {36},
  number = {13},
  doi = {10.1002/adfm.202517631}
}
Kostenlos starten →